Pramipexole (Mirapex)
ATI-format individual drug card with NCLEX-focused assessment, safety, teaching, and source attribution.
Neuroneeds review
Pramipexole (Mirapex)
ATI class: Dopamine agonist / Antiparkinson medication
Action
- ATI/source-folder candidate for Pramipexole (Mirapex); verify mechanism against the source table before validation.
Therapeutic use
- Review under Neuromuscular Disorders medication safety.
Nursing assessment
- Assess motor response, daytime sleepiness, hallucinations, and impulse-control behaviors.
- Check orthostatic blood pressure and fall risk.
- Review renal function for dose safety when applicable.
Administration
- Verify route against the order and source table.
Side effects
- Verify common side effects against the source table.
Adverse effects
- Somnolence
- Sudden sleep episodes
- Orthostatic hypotension
- Hallucinations
- Impulse-control problems
Interactions
- Alcohol and sedatives can worsen CNS depression.
- Dopamine antagonists can reduce effect.
- Renally cleared drug exposure can rise with kidney impairment.
Contraindications
- Hypersensitivity to pramipexole
Precautions
- Use caution with psychosis, older adult fall risk, and activities requiring alertness.
- Dose adjustment may be needed with renal impairment.
Client teaching
- Report sudden sleep episodes, hallucinations, compulsive behaviors, or severe dizziness.
- Avoid driving until response is known.
- Rise slowly and take fall precautions.
Medication outcomes
- Therapeutic response with no priority adverse effects.
Antidote / rescue
- No specific antidote is seeded; hold/question unsafe doses and manage toxicity per provider, facility, or poison-control guidance.
NCLEX priority cues
- Falling asleep during activities is a safety cue.
- New hallucinations can be medication-related.
- Orthostatic syncope outranks routine Parkinson teaching.
Medication classes
Source attribution
Google Drive source topic: Neuromuscular Disorders
google-drive
Sentinel pharmacology API reference
sentinel-api
Manual ATI-format NCLEX candidate normalization
manual-seed
Related study cards
Shows the medication class, ATI cues, source references, and connected study cards for this drug.
Med classmedication class
Dopaminergic agents
Boosts dopamine signaling to improve bradykinesia, rigidity, and tremor.
ATI cueInteraction
Alcohol and sedatives can worsen CNS depression.
ATI medication interaction concept.
ATI cueClass
Antiparkinson medication
ATI medication class concept.
ATI cueNursing Assessment
Assess motor response, daytime sleepiness, hallucinations, and impulse-control behaviors.
ATI medication nursing assessment concept.
ATI cueMechanism of Action
ATI/source-folder candidate for Pramipexole (Mirapex); verify mechanism against the source table before validation.
ATI medication mechanism of action concept.
ATI cueClient Teaching
Avoid driving until response is known.
ATI medication client teaching concept.
ATI cueNursing Assessment
Check orthostatic blood pressure and fall risk.
ATI medication nursing assessment concept.
ATI cueClass
Dopamine agonist
ATI medication class concept.
ATI cueInteraction
Dopamine antagonists can reduce effect.
ATI medication interaction concept.
ATI cuePrecaution
Dose adjustment may be needed with renal impairment.
ATI medication precaution concept.
ATI cueNCLEX Priority Cue
Falling asleep during activities is a safety cue.
ATI medication nclex priority cue concept.
ATI cueAdverse Effect
Hallucinations
ATI medication adverse effect concept.